The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

The rule of reason under Article 82 EC After Sot Lelos kai Sia

På svenska

Author

Summary, in English

Using Sot. Lelos kai Sia as a starting point, the main purpose of this paper is to investigate the trend of application of the rule of reason under Article 82 EC with respect to a refusal to supply in the European Union (EU) pharmaceutical market. In addition, some procedural issues deriving from this case and Syfait shall be analyzed in the beginning. In the light of that purpose, section 2 of this paper considers procedural concerns raised by those two cases with regard to the functioning of Regulation 1/2003. Section 3 then examines the application of the rule of reason under Article 82 EC to refusal to supply both before and in Sot. Lelos kai Sia. Moreover, section 4 identifies the issues which are still left open by this case. Next, section 5 considers potential developments towards a full fledged rule of reason under Article 82. Finally, section 6 draws implications for the pharmaceutical industry.

Publishing year

2009

Language

English

Document type

Working paper

Topic

  • Law

Keywords

  • refusal to supply
  • Article 82 EC
  • pharmaceutical sector
  • parallel trade
  • EU law
  • EU-rätt
  • rule of reason

Status

Submitted

Research group

  • EU Law